tiprankstipranks
Trending News
More News >
Tscan Therapeutics, Inc. (TCRX)
:TCRX
US Market
Advertisement

TScan Therapeutics (TCRX) Ownership - Who Owns TScan Therapeutics?

Compare
278 Followers

TScan Therapeutics (TCRX) Ownership Overview

20.20%7.01%44.62%5.57%22.60%
20.20% Insiders
44.62% Other Institutional Investors
5.57% ETFs
22.60% Public Companies and
Individual Investors
The ownership structure of TScan Therapeutics (TCRX) stock is a mix of institutional, retail, and individual investors. Approximately 57.20% of the company’s stock is owned by Institutional Investors, 20.20% is owned by Insiders, and 22.60% is owned by Public Companies and Individual Investors.
The ownership structure of TScan Therapeutics (TCRX) stock is a mix of institutional, retail, and individual investors. Approximately 51.63% of the company’s stock is owned by Institutional Investors, 20.20% is owned by Insiders, and 5.57% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
7,946,141Insider15.14%17,719,894
2,784,792Institution5.31%6,210,086
2,528,583Insider4.82%5,638,740
2,076,476Institution3.96%4,630,541
1,840,790Institution3.51%4,104,962
650,525Institution1.24%1,450,671
637,345Institution1.21%1,421,279
474,163Institution0.90%1,057,383
440,069Institution0.84%981,354
222,519Institution0.42%496,217

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
2,076,476Institution3.96%4,630,541
650,525Institution1.24%1,450,671
474,163Institution0.90%1,057,383
222,519Institution0.42%496,217
143,700Institution0.27%320,451
29,605Institution0.06%66,019
27,590Institution0.05%61,526
22,104Institution0.04%49,292
13,109Institution0.02%29,233
6,300Institution0.01%14,049

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
1,377,026Institution2.62%2,506,187
637,345Institution1.21%1,344,798
577,585Institution1.10%1,051,205
279,638Institution0.53%623,593
100,777Institution0.19%224,733
28,431Institution0.05%62,548
2,792Institution<0.01%5,891
1,986Institution<0.01%4,429

FAQ

Who Owns Tscan Therapeutics, Inc. (TCRX)?
According to the latest TipRanks data, approximately 44.62% of the company's stock is held by institutional investors, 20.20% is held by insiders, and 22.60% is held by retail investors.
    What percentage of Tscan Therapeutics, Inc. (TCRX) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 44.62% of Tscan Therapeutics, Inc. (TCRX) stock is held by institutional investors.
      What percentage of Tscan Therapeutics, Inc. (TCRX) stock is held by retail investors?
      According to the latest TipRanks data, approximately 22.60% of Tscan Therapeutics, Inc. (TCRX) stock is held by retail investors.
        Who owns the most shares of Tscan Therapeutics, Inc. (TCRX)?
        Lynx1 Capital Management LP owns the most shares of Tscan Therapeutics, Inc. (TCRX).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis